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Sodium restriction is important in the treatment of chronic
kidney disease; however, it is sometimes difficult to achieve.
Decreased taste sensitivity may be a factor influencing
inadequate control of oral salt intake and subsequent high
blood pressure. To measure this, the gustatory threshold
(recognition and detection) for salty taste was determined
in 29 patients with chronic kidney disease using a sodium-
impregnated test strip and relevant factors determining
taste sensitivity were analyzed. Compared with 11 healthy
volunteers, recognition and detection thresholds were
increased in the patients with chronic kidney disease. Oral
sodium intake correlated positively but serum zinc correlated
negatively with the recognition threshold. Patients with
diabetic nephropathy had a higher detection threshold
than non-diabetic patients. Both recognition and detection
thresholds were increased in patients with diuretic
administration. After 1 week of sodium restriction, the
average recognition threshold decreased significantly.
Our study verified that latent taste dysfunction and zinc
deficiency are common in patients with chronic kidney
disease. Further, the recognition threshold for salty taste
improved even after a short period of salt restriction.
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It is well known that excessive oral salt intake may induce
high blood pressure in salt-sensitive individuals.1,2 In
addition, high blood pressure is widely known to be an
important predictor for progression to end-stage renal
disease and several clinical trials have proved that appropriate
blood pressure control was required to prevent the progres-
sion of chronic kidney disease (CKD).3–8 High blood pressure
due to CKD is generally salt-sensitive, non-dipper (less than
10% of nocturnal blood pressure decline) and sometimes
intractable.3 Thus, sodium restriction is quite a beneficial
and reasonable treatment for high blood pressure in CKD
patients; however, sodium restriction is sometimes difficult
to achieve and excessive restriction affects a patient’s quality
of life.
One candidate factor relevant to the disturbance of salt
restriction is impaired sensitivity to salty taste. If the patient
cannot sense salty taste accurately, oral sodium intake may
increase. To assess taste acuity, two different gustatory
thresholds, the recognition and the detection threshold, are
used. The detection threshold was defined as the concentra-
tion of solution at which the subjects clearly indicated it as
different from deionized water, but not necessarily recogniz-
ing the type of stimulus. The recognition threshold was
defined as the concentration of a solution at which the
subjects clearly and accurately identified the type of stimulus,
that is, the taste.9 Sensitivity for salty taste differs among
individuals and is influenced by various causes, such as aging,
zinc status or both.10–12 One clinical experience proved that
excess sodium intake increases the taste threshold for salty
taste.13 In addition, concerning the effect of sodium
restriction on the gustatory threshold for salty taste, only
one clinical experiment in young human volunteers
showed that 10-day sodium depletion decreased the sodium
threshold.14
On the basis of these previous investigations, we
hypothesized that taste acuity is impaired in CKD patients
and is improved by appropriate sodium restriction. The
purpose of this study was to analyze the gustatory threshold
for salty taste in CKD patients using a sodium-impregnated
test strip (SALSAVE; Advantec Toyo Co. Ltd, Tokyo, Japan)
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and we also investigated the effect of short-term salt
restriction on the gustatory threshold.
RESULTS
Patient characteristics
The patient characteristics shown in Table 1, showed that
their renal function was moderately altered and a moderate
amount of urinary protein was observed. The primary causes
of CKD included 10 diabetic nephropathy, four hypertensive
nephrosclerosis, 13 chronic glomerulonephritis and two
others. In our patients, mean 24-h blood pressure was
relatively well controlled (24-h average blood pressure:
130.3±16.6/70.1±11.7 mm Hg) by several antihypertensives
(mean classes of administered antihypertensives: 2.38±1.54),
however, the circadian rhythm of blood pressure was
severely disturbed (average nocturnal blood pressure decline:
3.1±5.9%) and only three patients (10.7%) presented with
the dipper type of blood pressure. Mainly, angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-2 receptor
blocker (72%) and calcium channel blocker (72%) were
used and diuretics was administered for 12 patients (41%).
Average serum zinc was relatively low and serum zinc was
severely decreased (lower than 60 mg per 100 ml) in 10
patients. Estimated oral protein intake calculated according
to Maroni’s formula15 did not correlate with the serum zinc
value (data not shown).
Increased salty taste threshold in CKD patients
In our analysis, as a normal control, recognition and
detection thresholds were measured in 11 healthy age-
matched volunteers. Seventy-one percent of CKD patients
presented with a recognition threshold above 0.8%, which
was 27% in healthy volunteers (Figure 1a). In addition, 39%
of CKD patients presented with a detection threshold above
0.8%, whereas it was 18% in healthy volunteers (Figure 1b).
The recognition threshold was significantly higher in CKD
patients than in healthy volunteers (0.86±0.26 vs 0.68±
0.14%, Po0.05; Figure 1c). The detection threshold was
also significantly higher in CKD patients than in healthy
volunteers (0.74±0.21 vs 0.64±0.08%, Po0.05; Figure 1c).
Although the detection threshold obviously never exceeded
the recognition threshold, a discrepancy was observed in
10 patients (Figure 1d).
Significant correlation between urinary sodium excretion and
salt taste acuity
Multivariate analysis of the factors relevant to the increase in
the recognition threshold for salty taste revealed that high
urinary sodium excretion, low serum zinc, diabetic patients
and diuretics administration significantly correlated with
taste acuity in CKD patients. Twenty-four-hour sodium
excretion, as an indicator for evaluating the amount of
dietary sodium intake, correlated positively and significantly
with the recognition threshold (r¼ 0.57, Po0.01, Figure 2a),
not with the detection threshold in CKD patients (r¼ 0.45,
not significant (NS), Figure 2b). In contrast, serum zinc was
correlated negatively and significantly with the detection
threshold (r¼0.67, Po0.05, Figure 2d), but not with the
recognition threshold in CKD patients (r¼0.40, not
significant, Figure 2c).
Taste acuity impairment in patients with diabetic
nephropathy or diuretics administration
Concerning the genesis of CKD, the detection threshold
(0.88±0.28% in diabetic and 0.66±0.12% in non-diabetic
patients, Po0.05), but not the recognition threshold
(0.97±0.35% in diabetic and 0.82±0.23% in non-diabetic
patients, NS), was increased in patients with diabetic
Table 1 | Patient characteristics
CKD patients Normal subjects
Number of subjects 29 11
Age 62.9±15.9 37.7±8.62
Gender (M/F) 19/10 8/3
Smoking (Yes/No) 0/29 0/11
False teeth (Yes/No) 12/17 0/11
Diabetic nephropathy (Yes/No) 10/19 0/11
Laboratory parameters
Creatinine (mg per 100ml) 3.36±1.36 0.75±0.18
eGFR (ml/min/1.73m2) 20.85±12.2 89.8±8.9
Urinary protein (g/day) 2.21±2.67 Not available
Urinary sodium (mmol/day) 89.1±37.9 Not available
Serum zinc (mg per 100ml) 80–160 70.9±18.3 Not available
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Figure 1 |Gustatory threshold for salty taste in chronic kidney
disease (CKD) patients and healthy volunteers. (a) Distribution
of recognition threshold on admission. In all, 71% of CKD patients
presented with a recognition threshold above 0.8%, which was only
27% in healthy volunteers. (b) Distribution of detection threshold on
admission. A total of 39% of CKD patients presented the recognition
threshold above 0.8%, which was only 18% in healthy volunteers.
(c) Both the recognition and detection threshold were significantly
higher in CKD patients than in healthy volunteers. The detection
threshold was also significantly higher in CKD patients than in
healthy volunteers. (d) Single correlation between recognition
and detection thresholds. Nineteen patients presented with no
difference in concentration (closed circles); however, a discrepancy
was observed among 10 patients (open circles).
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nephropathy (Figure 3a). Serum zinc was not different
between diabetic and non-diabetic patients (66.7±17.7 mg
per 100 ml in diabetic and 73.1±18.4 mg per 100 ml in non-
diabetic patients, NS, Figure 3b). Concerning the admini-
strated antihypertensives, both recognition and detection
thresholds were increased in CKD patients with only diuretics
administration (recognition threshold; 1.03±0.35% with
diuretics and 0.76±0.13% without diuretics administration
(Po0.01), and detection threshold; 0.87±0.27% with
diuretics and 0.65±0.09% without diuretics administration
(Po0.01) Figure 3c). In addition, serum zinc was lower in
CKD patients with diuretics administration (63.5±16.0 vs
76.3±18.5 mg per 100 ml, Po0.05, Figure 3d). The age,
gender, use of false teeth, and degree of renal insufficiency did
not correlate with the recognition and detection thresholds
for salty taste in CKD patients. In addition, neither the
recognition nor detection threshold correlated with several
BP parameters, such as systolic, diastolic, mean, diurnal,
nocturnal and during 24 h in CKD patients.
Sodium restriction improves gustatory threshold for salty
taste
After 1 week of sodium restriction, the percentage of CKD
patients with a recognition threshold above 0.8% remarkably
decreased from 71 to 39% (Figures 1a and 4a). In addition,
the percentage of CKD patients with a detection threshold
above 0.8% decreased from 39 to 31% (Figures 1b and 4a).
The average value of the recognition threshold in CKD
patients decreased from 0.84±0.27 to 0.76±0.25% with
statistical significance (Po0.05). The average value of the
detection threshold in CKD patients also decreased from
0.74±0.21 to 0.71±0.23%; however, there was no statistical
significance (Figure 4b). To eliminate the possibility that
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Figure 3 | Impact of diabetes mellitus (DM) or the use of diuretics
on gustatory threshold. (a) Diabetic patients presented with a
remarkable increase in the detection threshold but not the
recognition threshold. (b) Serum zinc concentration was not
different between diabetic and non-diabetic patients. (c) Patients
with diuretics administration presented with both impaired
recognition and detection thresholds. (d) Serum zinc
concentration was remarkably decreased in patients with diuretic
administration.
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Figure 4 |One-week sodium restriction improves gustatory
threshold for salty taste. Sodium restriction was performed
only in chronic kidney disease (CKD) patients, not in healthy
volunteers. (a) Distribution of recognition threshold 1 week after
the examination. Approximately 42% of CKD patients presented
with a recognition threshold above 0.8%, which was only 18% in
healthy volunteers. (b) Distribution of detection threshold 1 week
after the examination. About 31% of CKD patients presented with
a recognition threshold above 0.8%, which was only 9% in healthy
volunteers. (c) The average value of the recognition threshold
decreased from 0.84 to 0.76% with statistical significance. In
contrast, the average detection threshold decreased from 0.74
to 0.71% with no statistical significance.
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Figure 2 |Correlation of gustatory threshold, urinary sodium
excretion, and serum zinc concentration. (a, b) There was a
positive and significant correlation between urinary sodium
excretion, indicating oral sodium intake, and the recognition
threshold; however, there was no significant correlation with the
detection threshold. (c, d) There was a negative and significant
correlation between serum zinc concentration and the detection
threshold; however, there was no significant correlation with the
recognition threshold.
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repeated tests affect the taste threshold, we examined the
same taste tests in healthy volunteers after a 1-week interval.
The percentage of healthy volunteers with a detection and
recognition threshold above 0.8% was decreased (27–18% in
recognition threshold; Figure 4a, 18 to 9% in detection
threshold; Figure 4b); however, the average value of both the
recognition and detection thresholds in healthy volunteers
was almost unchanged (recognition threshold: 0.68±0.14
to 0.65±0.09%, detection threshold: 0.64±0.08 to
0.62±0.06 NS).
DISCUSSION
In this study, daily urinary sodium excretion, indicating oral
sodium intake, correlated with the recognition threshold for
salty taste, not the detection threshold. In addition, we
proved that sodium restriction improved the recognition
threshold for salty taste, but not the detection threshold.
Previous reports revealed that taste dysfunction was fre-
quently observed in CKD patients.16–20 Taste dysfunction in
CKD patients had various causes, such as metabolic
disorders, deficiencies of various micronutrients including
zinc, degree of kidney dysfunction, alterations of peripheral
nerve activity, and administered drugs. The fact that taste
acuity improved after the initiation of hemodialysis19
indicates that the accumulation of uremic toxins may be
partly responsible for the impaired gustatory threshold in
CKD patients.
Taken together, the amount of usual oral sodium intake is
one of the candidate factors influencing on the recognition
threshold for salty taste. In contrast, the detection threshold
is affected by metabolic disorders, such as low serum zinc, or
organic neural dysfunction, such as diabetic neuropathy.
Previous investigations concerning the relationship between
sodium intake and taste threshold are limited. Moreover,
these results are still controversial and showed that sodium
depletion by diuretics administration and/or sodium restric-
tion did not affect the taste threshold.14,21 In contrast,
Huggins et al. showed that a 2-week oral sodium tablet
administration increased the taste threshold. They also
showed that the increment in urinary sodium excretion was
linearly related to the taste threshold,13 which may be
congruent with our results.
Low serum zinc is a major cause of taste dysfunction and a
previous report showed that serum zinc was reduced in CKD
patients.22,23 Zinc is bound to gustin, an essential protein
involved in taste perception. Zinc deficiency induces gustin
deficiency and subsequent impairment of taste acuity.24 In
our analysis, albeit with a weak correlation, serum zinc
significantly correlated with the detection threshold, indicat-
ing that zinc deficiency might partly contribute to taste acuity
impairment. One candidate’s cause of zinc deficiency in CKD
patients is that appetite loss and subsequent inappropriate
food intake by uremia may induce deficiencies in multiple
micronutrients.18,19 As for other candidates, because zinc
intake is closely related to protein intake, a low protein diet
for CKD also accelerates zinc deficiency; however, our study
did not verify the effect of a low protein diet on zinc
deficiency. In addition, low serum zinc does not always reflect
total body deficiency but abnormal redistribution, based on
the fact that the zinc content of hair and erythrocytes is
normal even if serum zinc is reduced.22,23 The mechanism of
abnormal zinc redistribution is unknown; however, as serum
zinc increased after dialysis initiation, uremia might induce
abnormal zinc metabolism.23 On the basis of these con-
siderations, serum zinc is easily depleted and should be
evaluated in CKD patients.
Concerning the administered antihypertensives, our study
demonstrated that only diuretics administration increased
the gustatory threshold, which occurred partially through
zinc deficiency. Generally, diuretics improve sodium sensi-
tivity to blood pressure and also shift the blood pressure
circadian rhythm from non-dipper to dipper, as does dietary
sodium restriction,25,26 which is preferable to prevent CKD
and CVD. The mechanisms of zinc deficiency due to diuretics
are unclear. Some reports have shown that diuretics,
especially hydrochlorthiazide, increased the urinary excretion
of zinc.27–29 In contrast, other reports showed that diuretics
reduced the zincuretic effect of captopril by binding to its
sulphydryl group within the tubular lumen.30 From these
reports, the effects of diuretics on zinc metabolism are still
undefined, but warrant further and larger examination to
reach a clear conclusion.
The initial step in taste signal transduction occurs in taste
receptor cells located in the taste buds, which are innerved by
afferent neurons.31 Once substances coat the mouth, changes
in the taste receptor cell membrane occur and ion channels
open, subsequently allowing stimulus ions to enter directly
through the channels.31 The perception of salt and sour tastes
is thought to result from the interaction between ion
channels at the cell membrane, whereas sweet and bitter
tastes are dependent on protein-bound secondary messengers
within the cells.10,32 Curiously, a previous report showed taste
dysfunction in CKD patients, especially bitter and salty taste
sensitivity.20 The preferable effect of sodium restriction on
salt taste acuity may be induced by improved ion channel
sensitivity and subsequent recognition threshold improve-
ment. In contrast, based on the fact that both zinc deficiency
and diabetic nephropathy patients showed an increased
detection threshold, our results suggested that the increased
detection threshold was caused by impaired subsequent
signal transduction, such as gustin deficiency or peripheral
nerve dysfunction. A previous report showed that the taste
nerve transduction function is impaired during the diabetes
course and that the strongest associations with taste
dysfunction were found with peripheral neuropathy and
microalbuminuria.33
Several methods, such as the whole-mouth method, the
micropipette method and the electrogustometer are used to
measure the gustatory threshold for salty taste in clinical
practice;34–36 however, these methods are complicated and
not suitable for routine clinical screening. In contrast,
SALSAVE examination is easy and inexpensive, and takes
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only a few minutes. In addition, the mean magnitude of the
response to SALSAVE significantly correlated with the results
of other taste tests.36 Thus, a taste test using SALSAVE is
useful for screening for salty taste dysfunction.
Our study has several limitations, such as the small
sample size, leading to inadequate assessment. For example,
although advanced age and the use of false teeth induce taste
dysfunction,37 our analysis did not provide a significant
correlation between these parameters and taste dysfunction.
Concerning the taste threshold examination, although
SALSAVE can easily evaluate the gustatory threshold for
salty taste in screening, impregnated sodium concentrations
of SALSAVE are limited on the market and we could not
evaluate the patient’s taste threshold accurately, especially
lower than 0.6% and higher than 1.6%. In our analysis,
although the threshold in most healthy volunteers was 0.6%
at the first and second examinations, we could not eliminate
the possibility that the threshold was overestimated. In
addition, the inter-trial interval can significantly influence
the taste threshold. Theoretically, a shorter inter-trial interval
might enhance adaptation and thus elevate the threshold.38
Furthermore, when determining each threshold, strips of
higher salt concentration were applied once followed by strips
with lower concentration, which might also enhance the taste
threshold; however, during our experiments, we considered
that oral rinsing with distilled water might be sufficient to
eliminate residual salt stimulus.
Finally, we used 24-h urinary sodium excretion as an
indicator of the amount of sodium intake. Although 24-h
urinary sodium excretion, if complete, has been used broadly
as the estimated daily sodium intake in many clinical
investigations,39–42 it is considered to be equal to sodium
intake only at the equilibrium blood pressure calculated from
the natriuresis–blood pressure curve proposed by Guyton.43
In our experiment, to minimize the effect of sodium
restriction under hospitalization and to assess the pre-
hospitalized salt intake, urinary sodium excretion measured
just after hospitalization was used for analysis; however, there
is a possibility that sodium excretion was not assessed
precisely and might have been lower than at home. In
addition, because the urine sample was measured only once,
the samples did not accurately reflect the daily variation of
urinary sodium excretion. We cannot exclude the possibility
that these limitations affected the results of our analysis.
In conclusion, we verified that taste dysfunction and zinc
deficiency are common in CKD patients. In addition, even
during a short period, sodium restriction improved the
recognition threshold for salty taste. To restrict sodium easily
and effectively to treat hypertension, physicians should be
more concerned with taste disturbance in CKD patients and
taste acuity should be assessed in the usual clinical practice.
MATERIALS AND METHODS
Subjects
In this study, we enrolled 29 CKD patients (mean age: 62.9±15.9
years old, 19 men and 10 women), defined as having eGFR below
60 ml/min/1.73 m2. All were consecutive patients who were admitted
to the hospital of Kyoto Prefectural University of Medicine to attend
a 1-week educational program on CKD. During hospitalization, a
meal with low salt (5 g/day), low protein (0.8 g/kg/day ideal body
weight) and low potassium (1500 mg/day) was served to all patients.
The calories were not altered for either diet, unless the patient had
diabetes mellitus. We ascertained whether the subject was a current
smoker and wore false teeth. In addition, 11 volunteers (mean age:
37.7±8.62 years old, eight men and three women) without renal
insufficiency (eGFR: 77–101 ml/min/1.73 m2, average eGFR 89.8±
8.9 ml/min/1.73 m2) or any serious systemic diseases were enrolled
to measure taste acuity. The research protocol was approved by the
institutional review board of the hospital of Kyoto Prefectural
University of Medicine and all patients gave written consent to this
study.
Blood and urinary examination and blood pressure
measurement
We measured serum creatinine (Cr; mg per 100 ml) on admission
and eGFR according to the MDRD formula as described
previously.44 Serum zinc, a major cause of taste dysfunction,
was also measured using fasting blood in the morning. A urine
sample was collected for 24 h from 1100 hours on the admission
day to the same time the next day and urinary sodium excretion,
urinary urea nitrogen excretion, and the amount of urinary
protein were measured. Simultaneously, ambulatory blood
pressure (ES-H531; TERUMO Corporation, Tokyo, Japan) was
monitored for 24 h and blood pressure was measured every 15 min
during the day and every 30 min at night. Mean blood pressure was
defined as diastolic blood pressure plus one-third of the pulse
pressure.
Gustatory threshold for salty taste measurements
In CKD patients, on the admission day and 1 week later, we
measured two different gustatory thresholds; the recognition and
detection thresholds, as described previously.36 To assess the effect of
repeated tests on the taste threshold, we also measured the gustatory
thresholds in healthy volunteers after a 1-week interval. The
detection threshold was defined as the lowest concentration at
which a subject could distinguish a sodium-impregnated test strip
from a no-sodium strip (no salty taste). The recognition threshold
was defined as the lowest concentration at which a salty taste could
be recognized.9 The impregnated salt concentration was initially 0%
and increased in 0.2% intervals from 0.6 to 1.6%. The patients held
the test strips in their mouths for a few seconds to assess the salt
concentration and were then asked, ‘is there any taste? If yes, what
kind of taste?’ Before each application of a paper strip, the subjects
gargled with distilled water. Strips with increasing salt concentration
were applied until the subject correctly identified any taste. The
same concentration was reapplied, and if the subject could not
identify the taste, the next highest concentration was presented.
When the same concentration had been correctly identified two
times, strips with successively lower concentrations were applied
until the subject made an incorrect identification in one of the two
applications. The next highest concentration was considered to be
the detection threshold. In addition, if the patients could taste
something, but failed to identify the correct taste of ‘salty’, the
examination was continued until they could identify the taste
correctly. The recognition threshold was determined as the next
highest concentration at which the subjects could correctly identify
‘salty’ two times.
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Statistical analysis
A statistical analysis was performed using StatView – SAS institute
Inc., version 5.0 software. All values are expressed as the mean±
s.e.m. when applicable. Spearman’s correlation coefficient by rank
was used to analyze the correlation between the gustatory threshold
and measurements such as blood and urine examination, blood
pressure and so on. Multivariate analysis was performed with the
gustatory threshold as a dependent variable and age, gender, the
degree of renal dysfunction, urinary sodium excretion and serum
zinc as independent variables. Student’s unpaired t-test and the
Mann–Whitney test were used to evaluate differences in several
variables. P-values less than 0.05 were considered significant.
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